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ORIGINAL ARTICLEAutosomal Recessive Keratoderma-
Ichthyosis-Deafness (ARKID) Syndrome
Is Caused by VPS33B Mutations
Affecting Rab Protein Interaction
and Collagen Modification
Robert Gruber1,2,12, Clare Rogerson3,4,12, Christian Windpassinger5,12, Blerida Banushi3,4,
Anna Straatman-Iwanowska3,4, Joanna Hanley3,4, Federico Forneris6, Robert Strohal7, Peter Ulz5,
Debra Crumrine8, Gopinathan K. Menon9, Stefan Blunder1, Matthias Schmuth1, Thomas Mu¨ller10,
Holly Smith3, Kevin Mills4, Peter Kroisel5,13, Andreas R. Janecke2,10,13 and Paul Gissen3,4,11,13In this paper, we report three patients with severe palmoplantar keratoderma associated with ichthyosis and
sensorineural deafness. Biallelicmutationswere found inVPS33B, encodingVPS33B, a Sec1/Munc18 familyprotein
that interacts with Rab11a and Rab25 proteins and is involved in trafficking of the collagen-modifying enzyme LH3.
Two patients were homozygous for the missense variant p.Gly131Glu, whereas one patient was compound het-
erozygous for p.Gly131Glu and the splice site mutation c.240-1G>C, previously reported in patients with
arthrogryposis renal dysfunction and cholestasis syndrome. We demonstrated the pathogenicity of variant
p.Gly131Glu by assessing the interactions of the mutant VPS33B construct and its ability to traffic LH3. Compared
with wild-type VPS33B, the p.Gly131Glu mutant VPS33B had reduced coimmunoprecipitation and colocalization
with Rab11a and Rab25 and did not rescue LH3 trafficking. Confirming the cell-based experiments, we found
deficient LH3-specific collagen lysine modifications in patients’ urine and skin fibroblasts. Additionally, the
epidermal ultrastructure of the p.Gly131Glu patients mirrored defects in tamoxifen-inducible VPS33B-deficient
Vps33bfl/fl-ERT2 mice. Both patients and murine models revealed an impaired epidermal structure, ascribed to
aberrant secretionof lamellarbodies,whichareessential forepidermalbarrier formation.Our resultsdemonstrate
that p.Gly131Glu mutant VPS33B causes an autosomal recessive keratoderma-ichthyosis-deafness syndrome.
Journal of Investigative Dermatology (2017) 137, 845e854; doi:10.1016/j.jid.2016.12.010INTRODUCTION
Palmoplantar keratoderma (PPK) denotes hyperkeratosis of
palms and soles. The inheritance pattern, phenotype char-
acteristics, and location of the hyperkeratosis as well as the
presence of additional extracutaneous features form the basis
of classification of different types of PPK (Has and Technau-
Hafsi, 2016; Lucker et al., 1994; Schiller et al., 2014).
Mutations in more than 20 genes have been associated with
both isolated and syndromic forms of hereditary PPK. There
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(VWS; Online Mendelian Inheritance in Man [OMIM]. Johns
Hopkins University, Baltimore, MD. MIM Number: 124500.
http://www.ncbi.nlm.nih.gov/omim/) and keratitis-ichthyosis-
deafness syndrome (OMIM. Johns Hopkins University, Balti-
more, MD. MIM Number: 148210. http://www.ncbi.nlm.nih.
gov/omim/). Both are generally inherited in an autosomal
dominant manner and caused by mutations in GJB2,
encoding a gap junction protein connexin 26. However,
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846is less severe in VWS. The phenotypic spectrum of GJB2-
associated PPK is broad, ranging from diffuse to mutilating
PPK with or without ichthyosis and keratitis (Janecke et al.,
2001, 2005; Maestrini et al., 1999; Richard et al., 2002).
Very rarely, VWS is due to a maternally inherited point
mutation in the mitochondrial MT-TS1 gene encoding mito-
chondrial serine tRNA. The resultant deafness is progressive,
postlingual, and involves high frequencies. Penetrance and
expressivity of this phenotype are variable, suggesting that
further modifying environmental and genetic factors are
involved (Sevior et al., 1998). Another severe form of auto-
somal dominant PPK is due to mutations in LOR, encoding
loricrin, an epidermal cornified envelope component
(Schmuth et al., 2004).
Here, we describe three patients with clinical, molecular,
and cellular features of an autosomal recessive PPK, associ-
ated with ichthyosis and deafness and caused by mutations in
VPS33B, from here on referred to as autosomal recessive
keratoderma-ichthyosis-deafness (ARKID) syndrome.
Mutations in VPS33Bwere previously reported as causal for
the rare autosomal recessive multisystem disorder arthrogry-
posis renal dysfunction and cholestasis (ARC) syndrome
(OMIM. Johns Hopkins University, Baltimore, MD. MIM
Number: 208085. http://www.ncbi.nlm.nih.gov/omim/)
(Gissen et al., 2004; Smith et al., 2012). Patients characteris-
tically present with congenital arthrogryposis often associated
with bilateral dislocation of the hips, flexion contractures of the
knee joints and rocker-bottom feet, renal proximal tubule
dysfunction, neonatal cholestasis, ichthyosis, and severe fail-
ure to thrive (Gissen et al., 2006). Additionally, patients display
sensorineural deafness, abnormal platelet a-granule biosyn-
thesis, and variable other symptoms including osteopenia,
absent corpus callosum, recurrent infections, and mild dys-
morphism (Gissen et al., 2006). Although most patients with
ARC syndrome die in infancy (Abu-Sa’da et al., 2005), three
reported patients with an attenuated form of ARC syndrome
survived into childhood (Bem et al., 2015; Smith et al., 2012).
VPS33B encodes the Sec1/Munc18 family protein VPS33B.
Sec1/Munc18 family proteins are known to regulate targeting
and fusion in vesicular trafficking events through their
interactions with soluble N-ethylmaleimide-sensitive-factor
attachment receptors (Carr and Rizo, 2010). VPS33B yeast
homolog Vps33p is a class c vacuolar protein sorting protein
required for protein trafficking to the yeast vacuole as part of
class c core vacuole/endosome tethering (CORVET) or homo-
typic fusion and vacuole protein sorting (HOPS) multiprotein
tethering complexes (Balderhaar and Ungermann, 2013; Sato
et al., 2000). Themammalian homologs ofVps33pareVPS33A
and VPS33B (Gissen et al., 2005). VPS33A has been shown to
form part of both the mammalian HOPS (Graham et al. 2013;
Wartosch et al., 2015) and CORVET complexes (Perini et al.,
2014), whereas VPS33B together with its protein partner
VIPAR (VPS33B-interacting protein involved in polarity and
apical protein restriction, also known as VPS16B and SPE39)
performs an independent function from HOPS and CORVET
complexes (Banushi et al., 2016).
Recessive mutations in VIPAS39 (VPS33B interacting pro-
tein, apical-basolateral polarity regulator, spe-39 homolog),
encoding VIPAR, cause ARC syndrome in cases without
VPS33B defects. VPS33B and VIPAR have been shown toJournal of Investigative Dermatology (2017), Volume 137form a stable protein complex that is implicated in apical
protein localization, phagosome-lysosome and endosome-
lysosome fusion, lysosome-related organelle biogenesis,
and integrin internalization (Akbar et al., 2011; Bem et al.,
2015; Cullinane et al., 2010; Galmes et al., 2015; Xiang
et al., 2015). Recently our group has shown that the com-
plex is required for delivery of the collagen-modifying
enzyme LH3, encoded by PLOD3 (procollagen-lysine, 2-
oxoglutarate 5-dioxygenase 3), to intracellular membrane-
bound pools of collagen through a vesicular trafficking
pathway involving Rab10 and Rab25 activity (Banushi et al.,
2016). LH3 is a collagen-modifying enzyme whose activity is
required for post-translational hydroxylation, galactosylation,
and glucosylation of collagen lysine residues (Salo et al.,
2006). Such modifications are essential for formation of
intermolecular crosslinks and thus stability of collagen
structures (Ruotsalainen et al., 2006; Sipila¨ et al., 2007).
Here we demonstrate a variant in VPS33B, to our knowl-
edge previously unreported, which disrupts interaction with
known partners and affects LH3 delivery to collagen leading
to ARKID syndrome in both homozygous and compound
heterozygous forms.
RESULTS
Identification of patients with PPK, ichthyosis, and
sensorineural deafness
Three patients of Austrian ethnic origin presented with PPK,
ichthyosis, and sensorineural deafness (Figure 1). Autosomal
recessive inheritance was implied by distant parental consan-
guinity (third-degree cousins once removed) in one case, and
observation of their identical rare surname and highly similar
clinical description in the other two patients. Two patients suf-
fered developmental delay and were not able to achieve inde-
pendent living as adults (patients 2 and 3), whereas one patient
(patient 1) had a normal cognitive and motor development.
Patient 1. Patient 1 (Figure 1a) is the first child of healthy
third-degree cousins once removed; his younger brother is
healthy. He was born at term by elective cesarean section
weighing 3.35 kg and passed the routine screening for
congenital hearing loss. Mild generalized ichthyosis and severe
PPK became evident in the first year of life. Moderate sensori-
neural bilateral symmetrical hearing loss requiring hearing aids
was recorded at 9 years old. Hearing loss predominately
affected the middle range with hearing thresholds at 50 dB for
sensation and 80 dB for word processing at 13 years old. Pro-
gressive hearing loss is also indicated by normal newborn
screening results but also by gradual worsening of follow-up
audiometric testing results. At the age of 13, he had normal
anthropometric data (height 167.4 cm, weight 54.4 kg, body
mass index 19.4 kg/m2) and his psychomotor development was
normal. He attended a mainstream school with average results
and recently went into training as a carpenter; no IQ tests were
performed. He had recurrent episodes of epistaxis during his
school years (not seen at investigation), and two episodes of
macrohematuria at 12 and 13 years old. Minimal relative pro-
teinuria (138 mg protein/g creatinine; reference: 0e100 mg/g)
with a total proteinuria of 40 mg/l (reference: 0e150 mg/l) and
mildly elevated systolic blood pressure (128/48 mm Hg) were
found. He does not receive treatment for this mild elevation in
Figure 1. Clinical features of the
three individuals with ARKID
syndrome. (a) Patient 1: 13-year-old
boy of medium height and build,
presenting with diffuse PPK,
sensorineural deafness, requiring
hearing aids, and generalized fine
scaling. (b) Patient 2: marked
palmoplantar hyperkeratosis,
generalized ichthyosis, contractures of
fingers, and acromicria in a 43-year-
old obese woman with sensorineural
hearing loss. (c) Patient 3: 49-year-old
man of normal weight showing
pronounced PPK with the absence of
the small toes after autoamputation,
generalized fine ichthyosis,
perimamillar hyperkeratosis, and
sensorineural deafness. ARKID,
autosomal recessive keratoderma-
ichthyosis-deafness; PPK,
palmoplantar keratoderma.
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l; reference: 30e89 IU/l) was present.
Patient 2. Patient 2 (Figure 1b) was born to healthy parents,
with no knowledge of consanguinity between them. Two sis-
ters and a brother were healthy. She was born at 41 weeks of
gestation weighing 3.73 kg. Congenital bilateral hip subluxa-
tion was treated surgically at 6 weeks and 2 years old. PPK and
mild-to-moderate generalized ichthyosis presented in infancy.
At 8 years old she was diagnosed with bilateral sensorineural
hearing loss and receivedhearing aids;wedonot havedetailed
information regarding this hearing loss. Her psychomotor
development was retarded. She was able to walk at 21/2 years
old. She attended school for thementally impaired from7 to 16
years old; no IQ tests were performed. Her understanding
seems to be normal; her pronunciation is unclear. She is able to
perform simple tasks at home, but appears unable to live alone,
thought to be due to difficulties in social interactions rather
than intellectual disability. Type 2 diabetes mellitus was diag-
nosed at 32 years old. When investigated at 43 years old, she
wasobesewith height 156cm,weight 107kg, bodymass index
43.3 kg/m2, and head circumference 53 cm,withmarked PPK,
generalized ichthyosis, contractures of different interdigital
joints of all fingers, and acromicria. There was no history of
cholestasis, edema, or evidence of bleeding disorders. Labo-
ratory investigations did not reveal signs of kidney and liver
disease. Brainmagnetic resonance imagingwas unremarkable
at the age of 35 years. She had a normal female karyotype
(550-band resolution), and a normal methylation-sensitive
multiplex-ligation-dependent probe amplification analysis
result of Prader-Willi syndrome testing.
Patient 3. Patient 3 (Figure 1c) was referred at 49 years old
for ichthyosis and severe PPK that had already caused mutila-
tion of the small toes by autoamputation. Hewore hearing aids
for bilateral sensorineural hearing loss diagnosed in adulthood;
we do not have detailed information regarding this hearing
loss. The patient had clubfeet at birth and trouble walking. He
wore an artificial denture, reportedly since childhood. He hada good language understanding by lip reading but hardly
intelligible speech. He did not finish school or job training and
displayed anxious and shy behavior; no IQ tests were per-
formed. He lived in a special care home. He developed
dyspnoea at 52 years old and was diagnosed with interstitial
lung fibrosis after approximately 3 months of worsening
symptoms; he did not smoke.Hediedunexpectedly at 59 years
old, soon after diagnosis, and no autopsy was conducted. His
earliermedical and family history could not be obtained. There
was no evidence for cholestasis, edema, or bleeding disorders.
Identification of mutations in the VPS33B gene
As initial screening for VWS candidate genes GJB2 (NCBI
reference sequence: NM_004004.5), LOR (NCBI reference
sequence: NM_000427.2), and MT-TS1 (NCBI chromosome
MT reference: NC_012920.1) did not reveal pathogenic
mutations, a whole-genome linkage scan was undertaken.
Linkage analysis was based on a subset of 39,000 single-
nucleotide polymorphisms (SNPs) with 50 kb distance and
a minor allele frequency of 0.15. A region of 3 Mb in size
on chromosome 15q26 was linked with the disease with a
significant logarithm of the odds score of 3.6 under the
hypotheses of autosomal recessive inheritance, and a distant
relationship of patients 2 and 3, who shared their surname
(Supplementary Figure S1 online). The region was flanked
by recombinant markers rs12914139 and rs493258
(Supplementary Figure S2 online). Subsequently, two private
sequence variants within this linkage region were identified
by exome sequencing in patients 2 and 3. Patient 3 had
two heterozygous variants in VPS33B, an alteration
c.[390G>A;392G>A] p.Gly131Glu, not previously identi-
fied in patients with ARC and to our knowledge previously
unreported, and a splice-site variant c.240-1G>C, previously
reported as causing ARC syndrome in homozygous form
(Smith et al., 2012). Patient 2 shared the VPS33B
c.[390G>A;392G>A] variant in homozygous form and also
a homozygous MAN2A2 (NM_006122, c.1400A>G,
p.Tyr467Cys) variant. Sanger sequencing confirmed the
VPS33B c.[390G>A;392G>A] variant in patients 2 and 3.www.jidonline.org 847
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Figure S3 online). The c.[390G>A;392G>A] variant local-
ized within a 1.8 Mb haplotype that was common to its five
disease chromosomes, and which did not contain the
MAN2A2 variant, indicating that the VPS33B
c.[390G>A;392G>A] variant was derived from a common
(Austrian) founder and that patient 3 was most likely com-
pound heterozygous for this variant and the splice-site mu-
tation. Unfortunately, this could not be confirmed, as
parental samples were not available for analysis. The two
variants were thus segregating appropriately in the pedigrees.
Both variants are rare, not listed in the Single Nucleotide
Polymorphism Database, Exome Sequencing Project, and
Exome Aggregation Consortium databases and absent from
300 anonymous blood donors from Western Austria.
The p.Gly131Glu variant affects delivery of known
VPS33B cargo
Patients with the p.Gly131Glu variant do not present with
characteristic ARC features, but share the less well-known
features of the disorder, that is, dry, scaly skin and sensori-
neural deafness. To confirm the p.Gly131Glu variant as
causative of the patients’ abnormalities, we investigated its
effect, using a previously established cell model of VPS33B
deficiency in murine inner medullary collecting duct
(mIMCD3) cell lines (Cullinane et al., 2010).
Overexpressed wild-type (wt) VPS33B interacts with
VIPAR, whereas ARC-mutant VPS33B has a substantially
reduced interaction with VIPAR (Cullinane et al. 2010).
In mIMCD3 cells, the p.Gly131Glu variant did not
affect colocalization with VIPAR (Figure 2aec) and
co-immunoprecipitation (co-IP) (Figure 2d) indicates that it
can still pull down VIPAR, suggesting that the p.Gly131Glu
change does not interfere with VPS33B tertiary structure
stability or VPS33B-VIPAR interaction. Our results are sup-
ported by in silico homology modeling, which demonstrated
that residue Gly131 localizes on the VPS33B molecular
surface (Figure 2e), in a solvent-exposed region unlikely to be
involved in the VPS33B-VIPAR interaction site, estimated to
be at a distance of over 20 A˚ in the homology model.
In VPS33B-deficient mIMCD3 cells, unlike wt cells, LH3 is
not delivered to intracellular collagen IV carriers and this
phenotype can be rescued by cotransfection of wt VPS33B
and VIPAR constructs into VPS33B-deficient cells (Banushi
et al., 2016). When cotransfected with VIPAR, the
VPS33B(p.Gly131Glu) construct could not rescue LH3
colocalization with collagen IV (Figure 3d), unlike the wt
construct (Figure 3c and e), suggesting that the p.Gly131Glu
variant disrupts the function of VPS33B in vesicular and
particularly LH3 trafficking.
Incorrect targeting of LH3 to intracellular collagen causes
abnormal post-translational modifications of collagen both
in vitro and in vivo (Banushi et al., 2016). In patients with
ARC syndrome, defects in LH3-mediated post-translational
modifications of collagen lysine residues can be detected
by mass spectrometry analysis of urine or cultured fibroblasts.
Patients with the p.Gly131Glu variant had reduced levels of
hydroxylysines, galactosyl hydroxylysines, and glucosylga-
lactosyl hydroxylysines in both urine (Figure 3f) and fibroblast
lysates (Figure 3g) compared with controls, which is similarJournal of Investigative Dermatology (2017), Volume 137to the reduction seen in patients with ARC. In addition, im-
munostaining of LH3 in the skin of a patient with ARKID
showed a decrease in punctate staining in dermal fibroblasts,
indicating disrupted LH3 distribution (Supplementary
Figure S4a online). These experiments support the conclu-
sion that the p.Gly131Glu variant is pathogenic and causes
ARKID syndrome allelic to ARC syndrome.
The p.Gly131Glu variant affects known VPS33B interactions
The VPS33B-VIPAR complex cooperates with Rab25, a small
GTPase (also known as Rab11c), and the activity of Rab25 is
necessary for VPS33B-VIPAR-dependent LH3 delivery to
intracellular collagen (Banushi et al., 2016). To determine
whether the p.Gly131Glu variant affected LH3 delivery to
intracellular collagen through disruption of this interaction,
we investigated the colocalization and interaction of VPS33B
with Rab25. In mIMCD3 cells, the VPS33B(p.Gly131Glu)
construct no longer colocalized with Rab25 (Figure 4aec)
and co-IP experiments showed a lower affinity between
VPS33B(p.Gly131Glu) and Rab25 compared with wt
(Figure 4g).
VPS33B-VIPAR has also been reported to interact with the
Rab11a small GTPase (Cullinane et al., 2010). Although this
interaction and the activity of Rab11a do not appear neces-
sary for LH3 delivery to intracellular collagen (Banushi et al.,
2016), Rab11a has recently been shown to be essential for
skin homeostasis, specifically for epidermal lamellar body
(LB) biogenesis (Reynier et al., 2016). LBs are lysosome-
related organelles containing, amongst other cargoes, lipids
and lipid-modifying enzymes that are secreted by granular
layer keratinocytes and are fundamental for the development
and maintenance of the epidermal barrier (Feingold, 2012;
Feingold and Elias, 2014). In mIMCD3 cells, the
VPS33B(p.Gly131Glu) construct no longer colocalized with
Rab11a (Figure 4def) and co-IP experiments demonstrated a
lower affinity between VPS33B(p.Gly131Glu) and Rab11a
compared with wt (Figure 4h).
The findings above suggest that the VPS33B region con-
taining the Gly131 residue may be important for interaction of
the VPS33B-VIPAR complex with Rab11 family proteins. This
region is characterized by numerous negatively charged resi-
dues,whose distribution on theVPS33B surfacemaybe critical
for molecular interactions (Figure 2e). The introduction of an
additional negative charge in this region by the p.Gly131Glu
mutation might indeed perturb Rab interactions without
inducing changes in the overall VPS33B fold or affecting its
interaction with VIPAR, which is predicted to bind in a region
distant from Gly131. In ARC syndrome, the VPS33B-VIPAR
interaction is disrupted, whereas in patients with ARKID, the
VPS33B-VIPAR interaction is intact whilst the Rab interactions
are affected. Therefore, it may be that the reduction in in-
teractions with Rab11a and Rab25 is at the core of skin defects
in patients with ARC and ARKID syndrome.
ARKID patient and Vps33bfl/fl-ERT2 mouse skin show
impaired epidermal structure
Hematoxylin and eosin staining of skin sections of patients
with ARKID showed acanthosis with extensive orthohy-
perkeratosis, hypergranulosis, and elongation of rete ridges
without signs of inflammation (Figure 5b). Ultrastructural
analysis by transmission electron microscopy revealed LB
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VPS33B or (b) YFP-VPS33B(p.Gly131Glu). Scale bars ¼ 10 mm. (c) Quantification of colocalization between VPS33B constructs and VIPAR. Data are mean 
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Myc-VIPAR. (e) Mapping of p.Gly131Glumutation on structuralmodels of the VPS33B-VIPAR complex. Left: VPS33B in orange and alpha solenoid region of VIPAR
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mIMCD3, murine inner medullary collecting duct 3; RFP, red fluorescent protein; WB, western blot; wt, wild type; YFP, yellow fluorescent protein.
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ARKID Syndrome due to VPS33B Mutationsentombment and inclusion of lipid bilayers within corneo-
cytes (Figure 5c and d), indicating entrapment of nonsecreted
LB contents, inhomogeneous LB secretion (Figure 5e) with
nonlamellar vesicular contents, and aberrant LB internal
structures, suggesting defective loading into the organelles.
This is similar to previous findings in ARC syndrome where
abnormal LB-like structures within the stratum corneum were
attributed to defects in LB secretion (Hershkovitz et al.,
2008).
Staining for the LB cargo kallikrein 5 in skin sections
of patients with ARKID showed a decrease in kallikrein 5
staining in granular keratinocytes and the stratum
corneum (Supplementary Figure S4b), suggesting thatVPS33B(p.Gly131Glu) could lead to epidermal barrier
defects by impairing LB biogenesis and/or secretion.
Additionally, transmission electron microscopy of the der-
moepidermal junction in ARKID abdominal skin sections
showed that the basement membrane was deficient
(Figure 5g) compared with control sections (Figure 5f).
Hemidesmosomes appeared less prominent and the number
of anchoring fibrils was clearly reduced. In addition, collagen
fibers were less fixed to fibrils and the overall number of
dermal collagen fibers appeared reduced, although quanti-
tative analysis was not performed.
We have recently described an inducible Vps33b knockout
mouse model for ARC syndrome (Bem et al., 2015).www.jidonline.org 849
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were analyzed. Scale bars ¼ 10 mm. Data are mean  standard deviation. ANOVA, analysis of variance; ARC, arthrogryposis renal dysfunction and cholestasis;
CFP, cyan fluorescent protein; LC-MS-MS, liquid chromatography tandem mass spectrometry; mIMCD3, murine inner medullary collecting duct 3; wt, wild
type; YFP, yellow fluorescent protein.
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Figure 4. VPS33B(p.Gly131Glu) alters VPS33B interaction with Rab25 and Rab11a. (a, b) Representative mIMCD3 cells coexpressing wt YFP-VPS33B (a) or
YFP-VPS33B(p.Gly131Glu) (b), RFP-VIPAR and CFP-Rab25. Scale bars ¼ 10 mm. (c) Quantification of the colocalization between VPS33B constructs and Rab25
in transfected mIMCD3 cells. Data are mean  standard deviation, unpaired t-test, **** P  0.0001. (d, e) Representative mIMCD3 cells coexpressing wt YFP-
VPS33B (d) or YFP-VPS33B(p.Gly131Glu) (e), RFP-VIPAR and Myc-Rab11a, stained with an a-Myc antibody. Scale bars ¼ 10 mm. (f) Quantification of the
colocalization between VPS33B constructs and Rab11a in transfected mIMCD3 cells. Data are mean  standard deviation, unpaired t-test, **** P  0.0001.
(g) a-HA co-IP on lysates of HEK293 cells coexpressing HA-VPS33B or HA-VPS33B(p.Gly131Glu) with Myc-VIPAR and Rab25-GFP. (h) a-HA co-IP on lysates of
HEK293 cells coexpressing HA-VPS33B or HA-VPS33B(p.Gly131Glu) with Myc-VIPAR and Rab11a-GFP. CFP, cyan fluorescent protein; co-IP, co-
immunoprecipitation; HA, hemagglutinin; HEK, human embryonic kidney; GFP, green fluorescent protein; IP, immunoprecipitation; mIMCD3, murine inner
medullary collecting duct 3; RFP, red fluorescent protein; wt, wild type; YFP, yellow fluorescent protein.
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Figure 5. Similar epidermal defects in
ARKID and Vps33bfl/fl-ERT2 mice. (a)
Control and (b) ARKID palmar skin,
H&E, scale bars ¼ 1 mm. (cee) ARKID
skin TEM (c) LBs (*) and (d) lipid
bilayers (arrows) within corneocytes,
(e) inhomogeneous LB secretion
(double arrows) and aberrant LBs,
scale bars ¼ 0.5 mm. (f, g)
Dermoepidermal junction in (f)
control and (g) ARKID abdominal
skin, anchoring fibrils (arrows),
scale bars ¼ 0.5 mm. (h) wt and (i)
Vps33bfl/fl-ERT2 dorsal epidermis,
H&E, scale bars ¼ 50 mm. (j) wt
and (k) Vps33bfl/fl-ERT2 epidermis
TEM: normal (white arrows) versus
entombed bilayers (black arrows),
aberrant LBs (*), scale bars ¼ 0.2 mm.
(l) aberrant LBs at the SG-SC interface
(double arrows), scale bar ¼ 2 mm.
ARKID, autosomal recessive
keratoderma-ichthyosis-deafness;
BM, basement membrane;
h, hemidesmosomes;
H&E, hematoxylin and eosin;
LB, lamellar body; SB, stratum basale;
SC, stratum corneum; SG, stratum
granulosum; SS, stratum spinosum;
TEM, transmission electron
microscopy; wt, wild type.
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852Hematoxylin and eosin and transmission electron micro-
scopy analysis of dorsal murine skin biopsies also show
acanthosis with hyperkeratosis and hypergranulosis
(Figure 5i), as well as abnormal LBs and inhomogeneous
secretion (Figure 5k and l). The analogy between ultrastruc-
tural defects in patients with ARKID and the ARC murine
model indicates similarities in the underlying causative
mechanism, strengthening the evidence that the p.Gly131-
Glu variant causes ARKID abnormalities.
DISCUSSION
The underlying pathology of the skin phenotype in VPS33B
deficiency has previously been attributed to defective LB
secretion (Hershkovitz et al., 2008), and Rab11a has recentlyJournal of Investigative Dermatology (2017), Volume 137been shown to be essential for LB biogenesis (Reynier et al.,
2016). We demonstrate here that the p.Gly131Glu variant
disrupts the interaction of VPS33B-VIPAR with Rab11a and
VPS33B deficiency causes abnormal formation of LB struc-
tures in mouse and human epidermis, suggesting that this
interaction with Rab11a is important for LB biogenesis.
Indeed, it may be that defects in intracellular trafficking of
cargoes to LB, or defects in LB secretion caused by loss of this
interaction are directly affecting keratinocyte differentiation
and epidermal morphology in patients with ARKID.
Collagens are a core component of various structures in
metazoans such as bones and basement membranes, and
are crucial for tissue structure and function, and their
assembly requires controlled processing and post-translational
R Gruber et al.
ARKID Syndrome due to VPS33B Mutationsmodification (reviewed in Ricard-Blum, 2011). LH3-dependent
post-translational collagen modifications are crucial for as-
sembly, secretion, and fibril stability of various collagens and
homeostasis of the basement membrane (Ruotsalainen et al.,
2006; Sipila¨ et al., 2007; Sricholpech et al., 2012). The ho-
meostasis of the basement membrane composition is essential
for the development and maintenance of tissue structure, po-
larity, and function (Morrisseyand Sherwood, 2015; Yurchenco,
2011).
We show that defective LH3 delivery in patients with ARKID
is associated with deficiency of anchoring fibrils and less
prominent hemidesmosomes indicating defects in the basement
membrane. This may explain some of the features observed in
these patients with VPS33Bmutations. This is further supported
by overlap in clinical findings, that is, arthrogryposis, sensori-
neural hearing loss, skin disease, psychomotor delay, and
impaired social communication between patients with ARKID
and a patient with LH3 deficiency (Salo et al., 2008). We have
shown, in VPS33B-deficient mice and mIMCD3 cells, that
abnormal LH3 delivery affects collagen homeostasis likely
producing alterations in the epidermal basement membrane,
changes in which could contribute to the dysregulation of LB
biogenesis and/or secretion and function.
VPS33B is ubiquitously expressed, including expression in
the vestibulocochlear ganglion (Diez-Roux et al., 2011), and
disruption of VPS33B-dependent intracellular protein traf-
ficking and collagen homeostasis may also underlie the
sensorineural deafness of patients with ARKID and ARC.
Polarized inner ear hair cells are affected by deficiencies in
protein trafficking and collagen homeostasis; mutations in the
unconventional myosins, for example, myosin VIIA, lead to
sensorineural deafness in Usher syndrome (OMIM. Johns
Hopkins University, Baltimore, MD. MIM Number: 276900.
http://www.ncbi.nlm.nih.gov/omim/), and mutations in
collagen IV a5 cause sensorineural deafness in Alport syn-
drome (OMIM. Johns Hopkins University, Baltimore, MD.
MIM Number: 301050. http://www.ncbi.nlm.nih.gov/omim/
). Therefore, defects in collagen homeostasis in VPS33B
deficiency may explain the similarities of both skin and
deafness symptoms in patients with ARKID and ARC.
In summary, the genetic and functional analyses described
here show that VPS33B(p.Gly131Glu) is the pathogenic
variant that in homozygous, or compound heterozygous
form, results in ARKID syndrome by impairing the role of
VPS33B in intracellular trafficking.
MATERIALS AND METHODS
This study was approved by the institutional review board of the
Medical University of Innsbruck and UK National Research Ethics
committee (REC13/LO/0168), and complied with the Declaration of
Helsinki Principles. Written, informed patient consent was obtained
for the experiments. Written consent for the publication of their
photographs was obtained from patient 2 and the parents of patient
1; an oral agreement was obtained from patient 3 and so we have
not shown his face. Expanded methods and reagent details can be
found in the Supplementary Materials and Methods online.
Linkage analysis and whole exome sequencing
DNA samples were hybridized to HumanCytoSNP-12v2 BeadChip
(Illumina, CA) arrays and whole-genome linkage scan wasundertaken. Whole-exome sequencing reads were aligned to the
human hg19 genome. After removing synonymous SNPs and SNPs
with allele frequencies >10% in the 1000 genomes dataset, there
were two SNPs left in each sample.
Vps33bfl/fl-ERT2 mice
Vps33bfl/fl-ERT2 mice have been described (Bem et al., 2015).
Immunofluorescence and co-IP analysis
mIMCD3 cells from ATCC CRL2123 were cultured as described
previously (Banushi et al., 2016). Colocalization, co-IP, and immu-
noblotting experiments were performed as described previously
(Banushi et al., 2016). Paraffin-embedded patient skin sections were
incubated in Histo-Clear (National Diagnostics, Atlanta, GA),
dehydrated in serial ethanol dilutions, and antigen retrieval per-
formed in citrate retrieval buffer (DAKO, Denmark). Sections were
blocked with 3% BSA (Sigma-Aldrich, Irvine, UK), 0.5% tween 20
(Sigma-Aldrich) in phosphate buffered saline; immunofluorescence
staining imaging was as described (Banushi et al., 2016).
In silico homology modeling and mass spectrometry analysis
Modeling, patient urine sample collection, fibroblast culture, and
mass spectroscopy were performed as described (Banushi et al.,
2016). Samples from patients with ARC (Banushi et al., 2016)
were used as positive controls.
Histology
Five-millimeter punch biopsies were taken from the skin of the palms
and abdomen. Specimenswere fixed in 4% formaldehyde, embedded
in paraffin, sectioned (6 mm), and stainedwith hematoxylin and eosin.
Mouse skin samples were fixed in 10% formalin (Sigma-Aldrich),
embedded in paraffin, and sectioned andprocessed by theBiomedical
Research Centre at the Institute of Child Health, London, UK.
Transmission electron microscopy
Patient samples were analyzed following both reduced osmium
tetroxide and ruthenium tetroxide postfixation protocols (Elias,
1996; Gruber et al., 2011). Murine skin biopsies were fixed in 4%
glutaraldehyde (TAAB, Berks, UK) in 0.1 M sodium phosphate and
incubated with 1% osmium tetroxide (TAAB) 1.5% potassium ferri-
cyanide overnight at 4 C, then in 1% tannic acid (TAAB) overnight
before serial dehydration. Further steps and imaging were as
described (Banushi et al., 2016).
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